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In LC full scan basedMS screeningmethods correct mass assignment is essential. Parameters affecting
the accuracy of mass assignment, i.e., analyte concentration, complexity of the matrix, and resolving
power, were studied using typical examples from the field of residue and contaminant analysis in food
and feed. The evaluationwas carried out by analyzing samples of honey and animal feed, spikedwith
151 pesticides, veterinary drugs, mycotoxins, and plant toxins at levels ranging from 10 to 250 ng/g.
Analyses were performed using a single stage Orbitrap with resolving power settings varying from
10,000 to 100,000 (FWHM). For consistent and reliable mass assignment (2 ppm) of analytes at low
levels in complex matrices, a high resolving power (50,000) was found to be required. At lower
resolving power settings, the error in the assignment ofmass increased due to the coelution of analytes
with interferences at the same nominal mass. This negatively affected selectivity and quantitative
performancedue to the inability to use the requirednarrowmass-extractionwindows. In the case of the
less complex honey matrix, a resolving power of 25,000 was generally sufficient to obtain a mass
assignment error close to the typical instrument mass accuracy (2 ppm) down to low concentration
levels of 10 ng/g. (J Am Soc Mass Spectrom 2009, 20, 1464–1476) © 2009 Published by Elsevier Inc.
on behalf of American Society for Mass SpectrometryThe potential presence of residues and contami-nants is an important issue in the field of foodand animal feed safety. Consequently, legislation
has been established at both the national and interna-
tional level to protect consumers from exposure to food
toxicants (e.g., [1–5]). This results in the need for mon-
itoring and control of such compounds in the food
chain. With new toxicants being identified and increas-
ing consumer awareness, the number of compounds
and the demand for analysis continue to grow.
The variety of potential sample types is enormous. It
varies from raw materials of plant and animal origin to
finished processed food. Target compounds are mainly
small molecules with molecular weights in the range of
100–1000 Da (majority 200–400 Da). Typical examples
are residues of pesticides and veterinary drugs, natural
toxins, environmental contaminants, processing and
packaging contaminants, and spoilage markers. The
total number of compounds of interest is therefore very
high (thousands).
In analytical chemistry, there is a clear tendency to
combine and expand existing analytical methods within
the different contaminant classes and beyond [6]. This is
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doi:10.1016/j.jasms.2009.05.010more efficient (less methods  less costs) and more
information is obtained during analysis.
Currently, multianalyte methods are typically carried
out using high-performance liquid chromatography
(HPLC) coupled to triple quadrupole mass spectrometers
(QqQ-MS). Although themethods are highly selective and
yield precise, quantitative results, this approach has draw-
backs and limitations, which are inherent to the targeted
acquisition involved in the MS measurement:
• Optimization of acquisition parameters is required
for every single compound, resulting in extensive
method set-up (time-consuming)
• The number of compounds is limited in one instru-
mental method
• Only analytes included in the MS-acquisition method
will be detected
• Definition of acquisition-time windows is required
for each (group of) analyte(s). In practice, the correct
settings of these time windows needs constant atten-
tion to assure detection of the analyte
• Retrospective data analysis cannot be carried out
This in part, explains why for chemical screening meth-
ods there has been an increased interest in full scan
mass spectrometric analysis (i.e., untargeted measure-
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ters [7–12].
The sample extracts to be analyzed, in the case of
wide-scope screening, are highly complex due to the
use of simple generic sample preparation procedures
(often just extraction/dilution). The lack of selectivity
from this sample preparation step has to be compen-
sated for by selectivity in the instrumental analysis.
With legal residue limits in the order of ng/g, this
means that the full scan MS detection has to fulfill the
following requirements:
• High selectivity for every single compound in the
mixture
• High sensitivity
• Confirmation of compound identity
• Accurate quantification of analytes found
It has been shown that these requirements can be met
using mass spectrometers with high mass resolving
power and high mass accuracy. Food safety applica-
tions described in literature – using full scan analysis -
mostly describe the highly effective use of TOF-MS for
the detection and identification of pesticides in vegeta-
bles/fruits [8–10] and water [8], veterinary drugs in
milk [12] and meat [11], and perfluorinated compounds
in biota [7]. From these results it is clear, that high
accuracy of mass assignment, irrespective of the matrix,
the analyte and its concentration, is mandatory.
The accuracy of mass assignment in a measurement
can differ from the instrumental mass accuracy, which
usually is specified by the instrument vendors under
certain conditions. One main influence on the assign-
ment of masses is the ability of a mass spectrometer to
resolve two peaks on the m/z scale, which are close to
each other. When peaks are not (fully) resolved, the
resulting measured mass profile will be the sum of the
two individual mass profiles and the top of the com-
bined profile will lie somewhere in between the exact
masses of the two individual peaks, as has also been
pointed out elsewhere [13]. As a consequence, the mass
assignment, which is based on a centroiding algorithm
of the detected profile, will result in an incorrect mass
for the analyte (for illustration of this effect see Supple-
mental Figure 4, which can be found in the electronic
version of this article.) Note that instrument mass
accuracy itself is not affected by this phenomenon. A
different m/z region in the same mass spectrum can be
free of interferences and show correct mass assignment
of analytes.
Moving towards higher complexity of the samples
(high number of matrix peaks at high levels relative to
the analytes) the resolution power of a mass spectrom-
eter can become a key parameter for the correct assign-
ment of analyte masses. In the current work, emphasis
was placed on the evaluation of this effect in target
compound screening in real samples and its impact on
quantitation.For the evaluation, a recently introduced single stage
Orbitrap mass spectrometer was used. Since its first
description in 2000 [14] and its commercial introduction
in 2005, Orbitrap technology has demonstrated its high
resolving power and precise mass measurement capa-
bilities [15–18]. Until recently, this technology was only
incorporated in hybrid-MS systems and typically used
in the field of proteomics [19], and metabolomics [20].
With the introduction of a single stage mass spectrom-
eter, Orbitrap technology has become an attractive
option for full scan screening in the field of food safety.
Since the mass resolving power can be set by the user,
the effect of this parameter on the analytical perfor-
mance could be conveniently studied using one and the
same instrument.
For the evaluation, a set of 151 pesticides, veterinary
drugs, mycotoxins, and plant toxins in generic extracts
of honey and animal feed (10–250 ng/g) was analyzed
using resolving power settings between 10,000 and
100,000.
Experimental
Chemicals and Reagents
Reference standards. Analytical standards of pesticides,
mycotoxins, plant toxins, and veterinary drugs were
purchased as pure materials or as custom-made mixed
solutions. Details of suppliers are given elsewhere [6].
Stock solutions at a concentration of 100–2000
g/mL were prepared from the pure compound stan-
dards. For pesticides, veterinary drugs, and plant tox-
ins, methanol was used as solvent. Mycotoxins and
ergot alkaloids were dissolved in acetonitrile. From the
stock solutions and the purchased custom-made mix
solutions, spiking solutions were prepared in methanol.
Two mix-spike solutions were prepared, one containing
all pesticides and natural toxins (all at 1 g/mL) and
another one containing all veterinary drugs (at 0.1–5
g/mL, concentrations for individual compounds are
included in Table 1). The spike solutions were stored in
a freezer ( 18 °C).
Chemicals. Acetonitrile and methanol (all HPLC grade
or better) and HPLC grade water were purchased from
Fisher Scientific (Schwerte, Germany). Formic acid and
ammonium formate were obtained from Sigma-Aldrich
(Schnelldorf, Germany).
Sample preparation. Two samples were selected for this
work, one of intermediate complexity (honey) and one
highly complex feed matrix. Honey was obtained from
a local bee-keeper. The feed matrix was a commercially
available compound feed sold as horse feed. Com-
pound feeds are feedstuffs that are blended from vari-
ous raw materials and additives (more details can be
found in [6]).
Sample preparation was carried out according to a
recently described generic procedure that allows effi-
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Index Type Compound name Elemental composition Exact mass* RT (min) Stock (g/mL)
1 P/PT Nicotine C10H14N2 163.12298 1.18 1
2 P Propamocarb C9H20N2O2 189.15978 **** 3.37 1
3 VD Sulfachloropyridazine C10H10N4O2S 285.02078 3.54 5
4 PT Scopolamine C17H21NO4 304.1544 3.55 1
5 P Asulam C8H10N2O4S 231.04338 3.55 1
6 VD Levamisole C11H12N2S 205.07938 3.55 0.2
7 VD Sulfathiazole C9H9N3O2S2 256.02088 3.58 5
8 VD(m) Albendazole Amino Sulfone C10H13N3O2S 240.08008 3.61 5
9 PT Retrorsine C18H25NO6 352.1755 3.64 1
10 VD Lincomycin C18H34N2O6S 407.22108 3.65 5
11 VD Trimethoprim C14H18N4O3 291.14517 3.67 2.5
12 VD Sulfapyridine C11H11N3O2S 250.06448 3.67 5
13 PT Retrorsine-N-oxide C18H25NO7 368.1704 3.67 1
14 VD Isopyrin C14H19N3O 246.16009 3.69 5
15 VD Tulatromycine C41H79N3O12 403.7905 ** 3.69 5
16 VD Marbofloxacin C17H19FN4O4 363.14628 3.71 5
17 P Oxamyl C7H13N3O3S 220.07508 3.72 1
18 PT Seneciphylline C18H23NO5 334.1649 3.72 1
19 VD(m) 5-Hydroxy thiabendazole C10H7N3OS 218.03828 3.74 5
20 VD Sulfamerazine C11H12N4O2S 265.07538 3.77 5
21 PT Heliotrine C16H27NO5 314.1962 3.77 1
22 PT Seneciphylline-N-oxide C18H23NO6 350.1598 3.78 1
23 PT Atropine C17H23NO3 290.1751 3.79 1
24 VD Sulfamoxole C11H13N3O3S 268.07508 3.81 5
25 VD Norfloxacin C16H18FN3O3 320.14048 3.84 2.5
26 P Carbendazim C9H9N3O2 192.07678 **** 3.85 1
27 P Oxydemeton-methyl C6H15O4PS2 247.02218 3.85 1
28 VD Dapsone C12H12N2O2S 249.06918 3.85 0.5
29 VD Danofloxacin C19H20FN3O3 358.15618 3.86 3
30 VD Sulfamethizole C9H10N4O2S2 271.03178 3.86 5
31 VD Ciprofloxacin C17H18FN3O3 332.14048 3.86 0.5
32 VD Enrofloxacin C19H22FN3O3 360.17178 3.89 5
33 PT Senecionine C18H25NO5 336.1806 3.89 1
34 VD Azaperol C19H24FN3O 330.1976 3.91 0.1
35 VD Sulfamethoxypyridazine C11H12N4O3S 281.07028 3.95 5
36 VD Sulfadimethoxine C12H14N4O2S 311.08088 3.95 5
37 VD Sulfamethazine C12H14N4O2S 311.08088 3.95 5
38 VD Tolmetin C15H15NO3 258.11248 3.95 5
39 P Thiamethoxam C8H10ClN5O3S 292.02658 3.95 1
40 PT Senecionine-N-oxide C18H25NO6 352.1755 3.98 1
41 VD Sulfamethoxazole C10H11N3O3S 254.05938 4.06 5
42 VD Spiramycin C43H74N2O14 422.26428 ** 4.06 5
43 VD Sulfisoxazole C11H13N3O3S 268.07504 4.12 5
44 PT Senkikkine C19H27NO6 366.1911 4.12 1
45 VD Sulfamonomethoxine C11H12N4O3S 281.07028 4.16 5
46 P/VD Thiabendazole C10H7N3S 202.04338 4.18 5
47 VD Sulfadiazine C12H14N4O4S 251.05968 4.19 5
48 PT Acetyl-Seneciphylline C20H25NO6 376.1755 4.36 1
49 VD Ibuprofen C13H18O2 207.13796 4.39 1
50 P Dimethoate C5H12NO3PS2 230.00688 **** 4.46 1
51 VD(m) Amino flubendazole C14H10FN3O 256.08808 4.52 0.2
52 P Metamitron C10H10N4O 203.09278 4.54 1
53 VD Sulfadoxine C12H14N4O4S 311.08088 4.6 5
54 VD Tilmicosin C46H80N2O13 435.2903 ** 4.62 5
55 VD(m) Albendazole Sulfoxide C12H15N3O3S 282.09068 4.67 5
56 VD Pirlimycine C17H31ClN2O5S 411.1715 4.69 5
57 VD(m) Albendazole Sulfon C12H15N3O4S 298.08558 4.73 5
58 VD Sulfaquinoxaline C14H12N4O2S 301.07538 4.74 5
59 MT Aflatoxine G2 C17H14O7 331.0813 4.74 1
60 VD Tenoxicam C13H11N3O4S2 338.02637 4.76 5
61 P Thiacloprid C10H9ClN4S 253.03088 4.77 1
62 VD Ipronidazol C7H11N3O2 170.09238 **** 4.87 0.5
63 MT Ergosine C30H37N5O5 548.2868 **** 4.89 1Continued
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Index Type Compound name Elemental composition Exact mass* RT (min) Stock (g/mL)
64 MT Aflatoxine G1 C17H12O7 329.0656 4.92 1
65 MT Ergotamine C33H35O5N5 582.2711 5 1
66 P Metoxuron C10H13ClN2O2 229.07388 5.06 1
67 VD Haloperidol C21H23ClFNO2 376.1474 **** 5.1 0.1
68 VD Oxfendazole C15H13N3O3S 316.07503 5.19 1
69 MT Aflatoxine B2 C17H14O6 315.0863 5.2 1
70 P Carbeetamide C12H16N2O3 237.12338 5.22 1
71 P Pirimicarb C11H18N4O2 239.15028 5.23 1
72 VD Oxibendazole C12H15N3O3 250.27678 5.26 0.2
73 P Triasulfuron C14H16ClN5O5S 402.06338 5.26 1
74 VD Piroxycam C15H13N3O4S 332.06998 5.27 5
75 P Cyanazine C9H13ClN6 241.09628 5.29 1
76 P Thiophanate-methyl C12H14N4O4S2 343.05288 5.31 1
77 MT Diacetyoxyscirpenol C19H26O7 384.2016787 *** 5.37 1
78 P Imazamethabenz-methyl C16H20N2O3 289.15468 5.4 1
79 MT Aflatoxin B1 C17H12O6 313.0707 **** 5.41 1
80 VD Acetopromazine C19H22N2OS 327.1526 5.41 0.1
81 VD Tiamulin C28H47NO4S 494.3299 5.45 5
82 MT Ergocryptine C32H41O5N5 576.3181 5.48 1
83 P Propoxur C11H15NO3 210.11248 5.54 1
84 MT Ergocristine C35H39O5N5 610.3024 5.55 1
85 P Carbofuran C12H15NO3 222.11248 **** 5.6 1
86 VD Tylosin C46H77NO17 916.52648 **** 5.6 5
88 P Simazine C7H12ClN5 202.08538 5.84 1
89 VD Propyphenazone C14H18N2O 231.14918 6.01 2
90 VD Propionylpromazine C20H24N2OS 341.16818 6.06 0.1
91 P Ethiofencarb C11H15NO2S 226.08968 6.06 1
92 VD Flumequine C14H12FNO3 262.08738 6.21 5
93 VD Indoprofen C17H15NO3 282.1125 6.29 2
94 VD Chlorpromazine C17H19ClN2S 319.10298 6.3 0.2
95 P Chlorortoluron C10H13ClN2O 213.07888 6.34 1
96 P Fenpropimorph C20H33NO 304.26348 6.4 1
97 VD Josamycin C42H69NO15 828.47398 6.4 1
98 P Metalaxyl C15H21NO4 280.15438 6.47 1
99 P Isoproturon C12H18N2O 207.14918 6.57 1
100 P Difenoxuron C16H18N2O3 287.13898 6.59 1
101 P Spiroxamine C18H35NO2 298.27408 6.69 1
102 VD Isoxicam C14H13N3O5S 336.06487 6.69 5
103 VD Valnemulin C31H52N2O5S 565.36698 6.7 5
104 VD Albendazole C12H15N3O2S 266.09578 6.72 5
105 P Diuron C9H10Cl2N2O 233.02428 6.72 1
106 VD Fenbufen C16H14O3 255.10158 6.76 5
107 VD Meloxicam C14H13N3O4S2 352.04202 6.88 1.5
108 VD Sulindac C20H17FO3S 357.09552 6.89 5
109 MT T2 Toxin C24H34O9 484.25411 *** 6.91 1
110 P Azoxystrobine C22H17N3O5 404.12408 7.01 1
111 VD Robenidine C15H13Cl2N5 334.06208 7.04 1
112 P Clomazon C12H14ClNO2 240.07858 **** 7.11 1
87 P Imazalil C14H14Cl2N2O 297.05558 7.26 1
113 P Dimethomorph I C21H22ClNO4 388.13098 7.27 1
123 VD Flunixin C14H11F3N2O2 297.08458 7.32 5
114 P Methiocarb C11H15NO2S 226.08968 7.34 1
115 P Isoxaben C18H24N2O4 333.18088 7.36 1
116 P Paclobutrazole C15H20ClN3O 294.13678 7.43 1
117 P Dimethomorph II C21H22ClNO4 388.13098 7.5 1
118 VD Fenbendazole C15H13N3O2S 300.08008 **** 7.66 1
119 P Fenhexamid C14H17Cl2NO2 302.07088 7.79 1
120 P Iprovalicarb C18H28N2O3 321.21728 7.82 1
121 VD Phenylbutazone C19H20N2O2 309.15978 7.82 2.5
122 P Flufenacet C14H13F4N3O2S 364.07378 7.92 1
124 P Dodine C13H29N3 228.24338 8.31 1
125 P Fenoxycarb C17H19NO4 302.13868 8.34 1
126 MT Sterigmatocystin C18H12O6 325.0707 8.34 1Continued
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cants from various matrices [6].
To 2.5 g of sample, 5 mL of water was added and
mixed using a vortex. In case of the dry feed matrix, the
mixture was allowed to soak for 15 min. Then 15 mL of
acetonitrile containing 1% of formic acid was added and
the sample was extracted by end-over-end shaking for
1 h. The tube was centrifuged (10 min at 2000 rcf) and
the clear extract was used for fortification. The final
concentration of matrix equivalent in the extract was
0.125 g/mL.
To the extracts, aliquots of the stock-mix solutions, or
intermediate solutions thereof, were added such that
the matrix was not diluted by more than 10%. The
concentrations of the spiked extracts ranged from 1.25
to 31.25 ng/mL. Since the sample is diluted eight times
during the sample preparation, this corresponds to a
concentration range from 10 to 250 ng/g in honey or
feed samples. This was the concentration range for all
pesticides and natural toxins. For veterinary drugs, the
concentrations in the stock solutions varied (see Table 1)
and, consequently, were correspondingly higher or
lower. For sake of readability, this detail is not specified
in each of the figures and tables in the Results and
Discussion section, i.e., when reference is made to a
level of 10 ng/g, the actual levels for veterinary drugs
are different for each compound and vary from 1 ng/g
Table 1. Continued
Index Type Compound name Elemental c
127 P Spinosyn A C41H65N
128 VD Indomethacin C19H16C
129 VD Diclofenac C14H11C
130 P Neburon C12H16C
131 VD Niflumic acid C13H9F3
132 P Tebuconazole C16H22C
133 P Penconazole C13H15C
134 P Mefenpyr-diethyl C16H18C
135 P Propiconazole C15H17C
136 P Hexaconazole C14H17C
137 P Prochloraz C15H16C
138 P Diazinon C12H21N
139 P Fenchlorazole-ethyl C12H8Cl
140 P Phosalone C12H15C
141 P Pirimiphos-methyl C11H20N
142 P Benzoximate C18H18C
143 P Pyrazophos C14H20N
144 P Difenconazole C19H17C
145 VD Mefenamic acid C15H15N
146 P Fenoxaprop-p-ethyl C18H16C
147 P Furathiocarb C18H26N
148 P Pirimiphos-ethyl C13H24N
149 P Tralkoxydim C20H27N
150 P Pyridaben C19H25C
151 VD Lasalocid C34H54O
P  pesticide; VD  veterinary drug; MT  mycotoxins; PT  plant tox
*[M  H].
**[M  2H]2.
***[M  NH4]
.
****Quantitative evaluation.to 50 ng/g.LC-Orbitrap Analysis
The separation of the analytes were carried out using an
(U-)HPLC system (Thermo Scientific Accela; Thermo
Fisher Scientific, San Jose, CA, USA) equipped with a
reversed-phase C18 analytical column of 100 mm  2.0
mm and 4 m particle size (Synergi 4 m Hydro-RP 80
Å; Phenomenex, Torrance, CA, USA). The column tem-
perature was maintained at 35 °C. The injected sample
volume was 5 L.
Mobile phases A and B were water/5% methanol
and methanol/5% water, respectively, both containing
2 mM ammonium formate and 20 L formic acid/L.
The chromatographic method held the initial mobile
phase composition (100% A) constant for 1 min, fol-
lowed by a linear gradient to 55% B after 3 min, and a
linear gradient to 100% B after 9 min. This final condi-
tion was held for 11 min to ensure complete elution of
matrix from the column. The flow rate used was 300
L/min.
The HPLC system was connected to a single stage
Orbitrap mass spectrometer (Exactive), through a heated
electrospray interface (HESI-II; Thermo Fisher Scien-
tific, San Jose, CA, USA), operating in positive ioniza-
tion mode using the following operation parameters:
electrospray voltage: 2.8 kV; sheath gas: 19 arbitrary
units; auxiliary gas: 7 arbitrary units; all other source
osition Exact mass* RT (min) Stock (g/mL)
732.46808 8.38 1
358.08406 8.38 5
2 296.02398 8.38 5
O 275.07128 8.41 1
2 283.0689 8.57 5
308.15238 8.57 1
284.07158 8.7 1
O4 373.07168 8.82 1
O2 342.07708 8.85 1
O 314.08218 8.86 1
O2 376.03808 8.89 1
PS 305.10838 8.9 1
2 401.91318 8.93 1
PS2 367.99418 8.95 1
PS 306.10358 9.01 1
364.09468 9.05 1
PS 374.09338 **** 9.15 1
O3 406.07198 9.33 1
242.11758 9.4 5
362.07898 9.64 1
S 383.16348 9.75 1
PS 334.13488 9.92 1
330.20638 10.4 1
S 365.14488 **** 11.09 1
591.38918 11.4 2
)  metabolite.omp
O10
lNO4
l2NO
l2N2
N2O
lN3O
l2N3
l2N2
l2N3
l2N3
l3N3
2O3
5N3O
lNO4
3O3
lNO5
3O5
l2N3
O2
lNO5
2O5
3O3
O3
lN2O
8
in; (mparameters were automatically tuned for maximum
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m/z  1000 and minimum in-source fragmentation. The
automatic gain control (AGC) was set at a target value
of three million. Internal calibration was performed by
single point calibration using the background ion of
n-butyl benzene sulfonamide (n-BBS) at m/z 
214.08963 in positive mode and m/z  212.07507 in
negative mode.
Data processing was done by ToxID software (ver-
sion 2.1.1, Thermo Fisher Scientific, San Jose, CA, USA)
and manual validation.
Mass Spectrometer
Samples were introduced into the atmospheric pressure
ionization (API) source by a liquid chromatographic
system. Ions are transferred from the ion source
through four stages of differential pumping using rf-
only multipoles into a curved rf-only trapping quadru-
pole (C-trap). In the C-trap ions are accumulated and
their energy dampened using a bath gas (nitrogen). Ions
are then injected through three further stages of differ-
ential pumping using a curved lens system into the
Orbitrap analyzer, where mass spectra are acquired via
image current detection. The vacuum inside the Orbi-
trap mass analyzer is maintained below 1E-09 mbar. A
schematic is available in the Supplemental Figure 2.
Automatic control of the number of ions in the
Orbitrap is performed by measuring the total ion charge
using a short prescan before the analytical scan and by
calculating the ion injection time for the analytical scan
from this value. For high scan rates, the previous
analytical scan is used as a prescan to optimize the scan
cycle time without compromising automatic gain con-
trol. Ion gating is performed using a fast split lens setup
that ensures the precise determination of the ion injec-
tion time.
Evaluation Set-Up
A set of 151 pesticides, veterinary drugs, mycotoxins
and plant toxins (see Table 1) was chosen for this
evaluation. Based on injection of solvent standards, all
of these analytes gave a good chromatographic peak
shape and response. From this it would be expected
that the theoretical detection limit of the analytes in
samples should be of the order of 10 ng/g or lower,
taking into account the eight  dilution factor from the
sample preparation.
An LC-MS sequence was set up for injection of
spiked extracts of honey and horse feed (levels corre-
sponding to 0-10-25-50-100-250 ng/g in sample). Mea-
surements were done at four resolving power settings
(specified at m/z 200, FWHM) and scan speeds: 10,000
(10 Hz), 25,000 (4 Hz), 50,000 (2 Hz), and 100,000 (1 Hz).
It shall be noted that resolving power of an Orbitrap
mass spectrometer is inversely proportional to the
square root of m/z, meaning that a resolving power of
10,000 (100,000) defined at m/z 200 results in an effectiveresolving power of 8164 (81,640) at m/z 300. For better
readability, all resolving power settings mentioned in
this article are defined at m/z 200, if not specified
differently. Under the chromatographic conditions ap-
plied, at least eight data points across the peak were
obtained at the lowest scan speed (for illustration of the
effect of resolving power/scan speed on data points
across the peak, see Supplemental Figure 3). For eval-
uation of mass accuracy, the mass at the apex of the
chromatographic peak obtained in the extracted ion
chromatogram was used.
For evaluation of quantitative performance, a set
of spiked extracts was measured in triplicate with a
resolving power of 100,000. Extracted ion chromato-
grams were created for a subset of compounds (indi-
cated in Table 1) using a mass extraction window of
5 ppm.
Results and Discussion
General Considerations Regarding
Residue/Contaminant Screening with Full Scan
Mass Spectrometry
In full scan mass spectrometry measurements, selectiv-
ity is obtained by creation of extracted ion chromato-
grams (XICs) of quasimolecular ions of the compound
of interest. For trace level analysis in LC-MS, high-
resolution/accurate mass is generally used. This en-
ables data analysis using the XICs of the exact mass of
a quasimolecular ion with a narrow mass-extraction
window, which provides the required selectivity. As
will be shown in the next paragraph, the width of the
mass-extraction window substantially affects the selec-
tivity (i.e., number of interfering peaks in a certain
chromatographic time domain, signal-to-noise ratio).
The more narrow the setting of the mass-extraction
window, the higher the selectivity. Correct mass assign-
ment over the entire chromatographic elution profile of
the analyte is important because it directly affects the
width of the useable mass-extraction window in the data
evaluation. In addition, it is an important parameter for
peak assignment and identification/confirmation.
In broad screening methods, the full scan raw data
needs to be searched for high numbers of analytes. In
practice, it is not possible to do this manually, and
automated library-based screening is necessary. Ideally,
a list of tentatively detected targets should be automat-
ically generated after analysis. For each analyte on the
list, further examination of the available data, or even
additional analysis, is required for full confirmation of
compound identity. Since this takes additional time, it is
desirable to minimize the number of detected compo-
nents which are subsequently rejected. The number of
these so-called false positives can be minimized using
narrow mass-extraction windows and a low tolerance
for mass accuracy. However, too strict criteria may
result in analytes going undetected (false negatives) if
mass assignment obtained during the measurement
1470 KELLMANN ET AL. J Am Soc Mass Spectrom 2009, 20, 1464–1476turns out to be insufficient or unreliable. For this reason,
a thorough evaluation of mass assignment errors in
complex samples and understanding of the parameters
causing them is essential for automated broad screening
methods.
Mass Extraction Window and Selectivity
After full scan LC-MS analysis, exact masses of quasi-
molecular ions, within a specific mass window will be
extracted to search the data for the presence of residues
or contaminants. In principle, the selectivity obtained
during data evaluation increases with narrowing of the
Figure 1. Effect of mass extraction window o
pesticide pirimicarb (MH, C H N O , m/z11 19 4 2 theo.
feed matrix at 10 ng/g; resolving power: 100,000.mass-extraction window. This is illustrated in Figure 1
for the pesticide pirimicarb (C11H18N4O2) in an animal
feed matrix at the 10 ng/g level. Starting with an
extraction window of 50 ppm (12 mDa), a rather
unspecific chromatogram is obtained. Taking a closer
look at the expected retention time of pirimicarb (see
inserts in Figure 1), clearly the analyte peak is obscured
by interferences. By narrowing the mass-extraction win-
dow, the pirimicarb peak rises from the background
and the signal-to-noise ratio (S/N) steadily improves.
At 2 ppm, the analyte peak is fully resolved. For the
very complex sample injected into the system, only
three distinct peaks are seen in the entire chromato-
lectivity. Extracted ion chromatograms for the
39.15028, retention time  5.23 min) in animaln se
 2
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be achieved. Conversely, it also shows that MS detec-
tion alone, even at this resolving power, does not result
in unique analyte-specific detection, and that separation
before MS detection is still required.
Resolving Power and Mass Assignment for
Analytes in Real Samples
The use of narrow mass-extraction windows is only
feasible when the mass spectrometer provides sufficient
mass accuracy. Very good mass accuracy (5 ppm) has
been reported for different types of mass analyzers,
including TOF [21] and Orbitrap [16, 17]. These speci-
fications are usually established for mass measurement
of single isolated compounds. In the practice of multi-
residue analysis, even with preseparation using HPLC
or U-HPLC, analytes may co-elute with compounds
from the matrix, or even with each other. In case of
injection of complex mixtures, it is not unlikely that the
exact mass of a co-eluting compound is close to that of
an analyte. When the two mass profiles overlap (i.e., the
two masses are not fully resolved), the measured mass
profile is the sum of the two individual profiles. De-
pending on the difference between the two exact
masses, their relative abundance, and the width of the
individual mass profiles (which is determined by the
Figure 2. Effect of resolving power on assigne
(MH  297.05560, C14H14Cl2N2O, RT  7.26 m
RT  7.32 min. Upper figure: extracted ion chro
Bottom figures: mass profiles at two resolving poweresolving power of the MS), the top of the measured
mass profile lies somewhere in between the two exact
masses resulting in incorrect assignment of the mass of
the target analyte. Consequently, for a given extract
analyzed, the resolving power is a key parameter affect-
ing the correct assignment of masses for analytes in
residue analysis.
This is illustrated below by two examples in which
samples have been measured with a resolving power of
10,000 and 100,000. The first example shows the co-
elution of two analytes Imazalil and Flunixin, which
differ by 30 mDa in their exact masses (Figure 2). The
mass spectra at three time points across the Imazalil
elution profile shows a mass accuracy better than 2 ppm
for all measurements of the high resolving experiment,
but mass deviations up to 95 ppm were encountered for
the measurement at a resolving power set at 10,000.
This is due to Flunixin, which is partially coeluting with
Imazalil (dashed line), and could not be resolved at the
lower resolving power setting (R  10,000). Both ana-
lytes form a broad peak (A simulation for the theoretical
resolving power at m/z 300 (R  8200) can be found in
Supplemental Figure 4). The centroiding algorithm as-
signs a mass of 297.07214, which is 55.7 ppm apart of
the theoretical MH value of Imazalil (for Flunixin the
mass assignment error in this case is 43.4 ppm). A
resolving power setting of 100,000 provides more than
ss accuracy of two co-eluting analytes. Imazalil
nd Flunixin (MH  297.08454, C14H11F3N2O2,
grams (5 ppm and  100 ppm, respectively).d ma
in) a
mator settings 10,000 (10 k) and 100,000 (100 k).
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dently of each other, and consequently the masses are
assigned correctly for both.
In the second example, co-elution of an analyte with
matrix compounds occurs, resulting in interference at
the same nominal mass. This is a more severe issue,
since in complex samples elution behavior of matrix
compounds cannot be predicted and may also vary
between samples and even batches of the same sample
source. With increasing complexity of the matrix there
is an increasing risk to suffer from these interferences
This is exemplary depicted for Isopyrin (m/z 
246.16009); 25 ng/g) in animal feed (Figure 3). Measure-
ments were performed at four resolving power settings.
A good peak shape and mass assignment over the entire
chromatographic peak was observed at 100,000 and
50,000. With a resolving power of 25,000 the peak shape
deteriorated, since several data points showed mass
deviations that exceeded the mass tolerance window of
the XIC (5 ppm). At a resolving power of 10,000 this
resulted in a complete loss of analyte response.
Examining the associated mass spectra at the apex of
the chromatographic peak in the XIC for each resolv-
ing power shows an interference at m/z  246.17001
(i.e., 10 mDa difference with the target analyte). This
interference was resolved at the two higher resolving
power settings, but only partially at R 25,000 and not at
all at R  10,000. From Figure 3 it can be seen that at a
resolving power of 25,000 and below, the assignment of
masses is not reliable. Lower analyte concentration
and/or a higher interference concentration (which is more
or less a random variable), would result in substantial
mass deviation of Isopyrin already at a resolving power of
25,000, which, in turn, would result in a false negative
response during screening.
Figure 3. Effect of resolving power on assign
(C14H19N3O, RT  3.69 min; MH  246.16009,
ppm mass extraction window. Right-hand side
RT  3.69 min.From the above examples it becomes clear, that
precision of the mass measurement and, in addition,
correct assignment of masses, independent of the ma-
trix, is a prerequisite for using narrow mass extraction
windows, which, in turn, are required for reliable
qualitative and quantitative analysis of small molecules
in complex samples. To achieve this, a certain minimum
resolving power is needed, which depends on the
complexity of the sample and the concentration levels
of both analytes and interferences.
Resolving Power Requirements in
Residue/Contaminant Screening
To evaluate the application of full scan mass spectrom-
etry for generic chemical screening assays, more insight
into the resolving power requirements for precise mass
measurement is needed. As a first step to provide this
insight, the accuracy of mass assignment of all 151
analytes from Table 1 was determined for five concen-
tration levels (1.25–31.25 ng/mL corresponding to 10–
250 ng/g in the sample), at various resolving power
settings and for two types of samples. Honey was
chosen as a representative matrix of intermediate com-
plexity, horse feed was chosen as a realistic worst case
sample of high complexity. Honey and a compound
feed were also chosen because they are typical exam-
ples where various types of contaminants (i.e., pesti-
cides, veterinary drugs, and natural toxins) are rele-
vant, and where wide-scope screening assays are highly
beneficial.
In Table 2, a compilation of errors in the assigned
masses is made for the lowest and the highest resolving
power settings (i.e., 10,000 and 100,000). Since in routine
ass accuracy of an analyte in matrix. Isopyrin
/g in animal feed. Left-hand side: XICs with 5
s profiles of analyte and matrix interference ated m
25 ng
: mas
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ered not useful (lower selectivity, lower S/N, increased
rate of false positives), peaks with a mass deviation
 25 ppm were excluded from the results and flagged
as “not detected.” It should be noted that nondetection
can also be caused by reduced analyte response when
coeluting with matrix due to (1) ion suppression in the
ion-source and (2) exceeding the maximum dynamic
range for the mass spectrometer.
For the analysis of honey samples, the measurements
performed at R  100,000 showed excellent mass accu-
racy (2 ppm) down to the lowest concentration levels
for all analytes. Only one analyte out of 151 could not be
detected at the 10 ng/g level. The 10,000 resolving
power experiment showed increasing mass errors with
decreasing analyte concentrations. Even at the rela-
tively high levels of 250 and 100 ng/g, mass deviations
outside the instrument specification of 2 ppm were
observed for a number of analytes due to matrix inter-
ferences. These mass deviations increased to 10–25 ppm
at the lowest concentration levels.
As expected, for the more complex animal feed
extract, the effect of resolving power and analyte con-
centration on the correct assignment of masses was
much more pronounced. While excellent mass accuracy
was still obtained for virtually all analytes down to the
10 ng/g level at the highest resolving power, a resolv-
ing power of 10,000 was clearly insufficient to maintain
accurate mass assignment for the target compounds.
Even at the highest analyte concentrations, less than
50% of the analytes were detected with a mass accuracy
better than 2 ppm. In this complex matrix, the number
of correctly assigned masses decreased dramatically for
lower analyte concentrations. At the 10 ng/g level, 35%
(44 out of 151) of the analytes could not be detected
when using a mass extraction window of 25 ppm.
The effects of resolving power on mass assignment at
Table 2. Effect of resolving power, concentration and matrix on
Resolution  10,000
Concentration
ng/g
Mass deviation (ppm)
2 2–5 5–10 10–25
Honey
10 79 12 5 3
25 83 12 5 0
50 88 10 2 0
100 94 4 2 0
250 91 8 1 0
Animal feed
10 11 17 13 24
25 22 25 16 20
50 32 34 20 0
100 42 39 7 0
250 45 41 10 0settings between 10,000 and 100,000 was further studiedfor the analysis of honey and feed samples with an
analyte concentration of 25 ng/g at a resolving power of
25,000 and 50,000. These results are summarized in
Table 3. For honey, a resolving power of 25,000 was
sufficient to obtain assignments with excellent mass
accuracy for all analytes. Higher resolving power is not
strictly necessary for good screening performance in
this case. Using the intermediate resolving power (R 
25,000) enables faster scan rates (4 Hz and, therefore,
better compatibility with narrow peaks such as ob-
tained with U-HPLC). Alternatively, additional acqui-
sition events can be done (switching between positive
and negative ion mode, measurement with and without
fragmentation), which are outside the scope of this
paper. As can be seen from Table 3, higher minimum
resolving power is required in case of highly complex
matrices, such as animal feed. Aiming for a detection
rate of 95%, a resolving power setting of 50,000 is
sured mass deviation of residues and contaminants
of 151 analytes
Resolution  100,000
Mass deviation (ppm)
/ND 2 2–5 5–10 10–25 25/ND
1 99 0 0 0 1
0 100 0 0 0 0
0 100 0 0 0 0
0 100 0 0 0 0
0 100 0 0 0 0
5 93 1 0 0 6
7 99 0 0 0 1
4 99 0 0 0 1
2 100 0 0 0 0
4 100 0 0 0 0
Table 3. Effect of resolving power on mass assignment of
residues and contaminants* in a matrix of intermediate and
high complexity
% of 151 analytes
Mass deviation (ppm)
Resolution 2 2–5 5–10 10–25 25/ND
Honey
10,000 83 12 5 0 0
25,000 100 0 0 0 0
50,000 100 0 0 0 0
100,000 100 0 0 0 0
Animal feed
10,000 22 25 16 20 17
25,000 41 17 26 2 14
50,000 93 4 1 0 2
100,000 99 0 0 0 1mea
%
25
3
1
1
1*Concentration of analytes 25 ng/g.
1474 KELLMANN ET AL. J Am Soc Mass Spectrom 2009, 20, 1464–1476required for a mass deviation criteria of 5 ppm. With
a more stringent mass accuracy requirement of 2
ppm, a resolving power setting of 100,000 is needed.
Quantitative Aspects
Following the qualitative screening the next step is
quantification of the analytes found. Especially for
frequently detected analytes, (multi-level) calibration
standards may be analyzed together with the samples
to allow calculation of the concentration, or to estimate
the concentration relative to targeted legal limits.
It has already been shown (Figures 1 and 3), that the
mass-extraction window (i.e., resolving power and
mass assignment accuracy) has a significant impact on
selectivity and peak shape and, therefore, also on quan-
tification. This is illustrated in more detail in Figure 4.
Mass measurement of isoproturon in horse feed at a
resolving power of 10,000 (Figure 4e–h) resulted in a
mass assignment errors for several scans across the
chromatographic peak. Only a few data points across
the chromatographic peak had mass deviations below
2 ppm. Consequently, a “spike-like” peak is obtained
with a 2 ppm mass-extraction window. This will cause
inconsistencies for automated integration, and result in
an underestimation of the analyte concentration. Ex-
panding the mass extraction window to 5 ppm results
in quite a few more signals within this window, but the
chromatographic peak shape is still not sufficient for
Figure 4. Extracted ion chromatograms with di
and medium (10 k; e–h) resolving power of iso
ng/g in horse feed matrix. Also shown is the m
showing an resolved interference at m/z  207.
interference—not resolved from the analyte—in
for all windows (7.11 E4 and 7.30 E4, respectively).quantitation. Further increasing the window size to 10
ppm results in a peak shape, which is cut at the edges.
This situation does not improve up to a window size of
25 ppm. Re-analysis of the same sample at a resolving
power of 100,000 (Figure 4a–d), ensuring a correct mass
assignment of 2 ppm for all data points across the
peak, resulted in a good chromatographic peak shape
and consistent analyte response. The behavior at 10,000
resolving power in this case is caused by an unresolved
matrix interference (Figure 4, i and k), which is 11
mDa apart. Consequently for low analyte levels in
complex samples, high resolving power (50,000 or
higher) is necessary to avoid peak distortion when
using narrow mass-extraction windows, needed for
appropriate selectivity. Similar observations are also
made because of analyte-analyte interferences. As an
example, the XICs of Imalazil at different resolving
power settings and different extraction window sizes
are shown in the supplemental data (Supplemental
Figure 5).
The linearity of the analyte response for a range of
concentrations was studied for a subset of 14 analytes
(indicated in Table 1), representing the different molec-
ular weights and retention times, in the honey and feed
matrix.
The same general trends were observed for all ana-
lytes investigated. In honey, the slope of the response
curve was higher than in horse feed (Figure 5). This is
due to ion suppression within the electrospray ion
nt mass extraction windows at high (100 k; a–d)
ron (C12H18N2O) at a concentration level of 25
lar ion region at both resolving power settings,
in the R  100,000 spectrum (i) and the same
wer resolved mass spectrum (k). Absolute scaleffere
protu
olecu
13808
the lo
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which is usually more pronounced for samples with
high amounts of co-extractants. The deviation between
theoretical and calculated concentration, using the mea-
sured response and the equation of the calibration
curve, was determined. Using a linear fit without
weighing, this deviation was generally less than 20%
except for the lowest concentration level (10 ng/g). At
this level, a positive bias was observed for a number of
analytes (typically 30%–40%, and higher in some cases).
The accuracy in quantification could be improved using
a weighing factor (1/x) or quadratic fitting. An example
of the latter is shown in Figure 6. Using quadratic
fitting, the deviations were mostly less than 10% for all
concentration levels studied. The reason for the observed
nonlinear behavior of some analytes could not be readily
explained and is subject to further investigation.
Conclusions
Reliable qualitative screening and quantification in
food/feed toxicant analysis with LC coupled to high
mass accuracy MS detection is only possible when
correct masses are assigned throughout the entire ex-
periment. For this, the resolving power has to be
fit-for-purpose. Since the resolving power needed is
mainly determined by the ratio of the analyte concen-
tration relative to co-eluting matrix interferences, the
optimum setting depends on the type of sample, the
analyte concentration, and the sample preparation before
LC-MS analysis.
With straightforward generic extraction proce-
dures, typically used in broad screening methods, a first
evaluation shows that a resolving power of 7000–10,000
[ranges given here reflect the dependency of mass
resolving power on m/z with Orbitrap-MS, and corre-
spond to actual resolving power at m/z 400 and m/z 200,
respectively] can be sufficient for detection of analytes
in samples of intermediate complexity, at levels down
to 25 ng/g, with mass errors below 5 ppm. For lower
levels and/or more precise mass assignment, a higher
resolving power (18,000–25,000) is needed. In highly
Figure 5. Calibration curves (linear without weighing) for car-
bendazim in honey (upper) and horse feed (lower).complex extracts, a resolving power of 35,000–50,000 or
even 70,000–100,000 is required. This observation is in
agreement with results reported by others [13, 22]. A
more comprehensive exploration involving a wider
variety of matrices should give more insight in catego-
rization of complexity of samples.
Knowing about the minimum required resolving
power is useful for Orbitrap based experiments, since it
is directly linked to the scan speed. Although, in prin-
ciple, a maximum resolving power will provide the best
qualitative and quantitative performance, the use of
lower resolving power settings, where applicable, al-
lows the use of faster scan rates (better compatibility
with fast LC separation). From this work, it can also be
concluded that single stage Orbitrap-MS is a very useful
tool with high potential for efficient automated screen-
ing in the field of food and feed safety.
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